The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Vor Biopharma Inc shares valued at $2,557,261 were sold by RA CAPITAL MANAGEMENT, L.P. on Oct 27 ’25. At $28.12 per share, RA CAPITAL MANAGEMENT, L.P. sold 90,941 shares. The insider’s holdings dropped to 1,180,060 shares worth approximately $30.09 million following the completion of this transaction.
Also, RA CAPITAL MANAGEMENT, L.P. sold 76,880 shares, netting a total of over 2,153,409 in proceeds. Following the sale of shares at $28.01 each, the insider now holds 1,324,346 shares.
Before that, RA CAPITAL MANAGEMENT, L.P. had sold 53,345 shares from its account. In a trade valued at $1,494,193, the Director traded Vor Biopharma Inc shares for $28.01 each. Upon closing the transaction, the insider’s holdings decreased to 53,345 shares, worth approximately $32.41 million.
As published in a research note from Robert W. Baird on October 15, 2025, Vor Biopharma Inc [VOR] has been rated up from a Neutral to an Outperform and the price target has been revised to $64. Analysts at Stifel upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in late September. As of June 30, 2025, H.C. Wainwright has increased its “Neutral” rating to a “Buy” for VOR. Earlier on July 26, 2022, Wedbush initiated its rating. Their recommendation was “an Outperform” for VOR stock.
Analyzing VOR Stock Performance
On last trading session, Vor Biopharma Inc [NASDAQ: VOR] plunged -5.29% to $25.5. The stock’s lowest price that day was $23.12, but it reached a high of $26.79 in the same session. During the last five days, there has been a drop of approximately -3.77%. Over the course of the year, Vor Biopharma Inc shares have jumped approximately 75.43%. Shares of the company reached a 52-week high of $65.80 on 07/08/25 and a 52-week low of $2.62 on 05/09/25.
Support And Resistance Levels for Vor Biopharma Inc (VOR)
According to the 24-hour chart, there is a support level at 23.48, which, if violated, would cause prices to drop to 21.46. In the upper region, resistance lies at 27.16. The next price resistance is at 28.82. RSI (Relative Strength Index) is 36.08 on the 14-day chart, showing neutral technical sentiment.
Is Vor Biopharma Inc subject to short interest?
Stocks of Vor Biopharma Inc saw a sharp rise in short interest on 2025-10-15 jumping by 0.14 million shares to 1.24 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 1.1 million shares. A jump of 10.96% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.53 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.53.
Which companies own the most shares of Vor Biopharma Inc (VOR)?
In terms of Vor Biopharma Inc share price expectations, FactSet research, analysts set an average price target of 55 in the next 12 months, up nearly 104.31% from the previous closing price of $26.92. Analysts anticipate Vor Biopharma Inc stock to reach 64 by 2025, with the lowest price target being 55. In spite of this, 2 analysts ranked Vor Biopharma Inc stock as Buy at the end of 2025. On April 27, 2022, Goldman assigned a price target of “a Neutral” to the stock and initiated coverage with a $6.
